| Interleukin‐17+ CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression B Menon, NJ Gullick, GJ Walter, M Rajasekhar, T Garrood, HG Evans, ... Arthritis & rheumatology 66 (5), 1272-1281, 2014 | 312 | 2014 |
| In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses HG Evans, NJ Gullick, S Kelly, C Pitzalis, GM Lord, BW Kirkham, ... Proceedings of the National Academy of Sciences 106 (15), 6232-6237, 2009 | 255 | 2009 |
| Co-morbidities in established rheumatoid arthritis NJ Gullick, DL Scott Best practice & research Clinical rheumatology 25 (4), 469-483, 2011 | 186 | 2011 |
| BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs J Ledingham, N Gullick, K Irving, R Gorodkin, M Aris, J Burke, P Gordon, ... Rheumatology 56 (6), 865-868, 2017 | 165 | 2017 |
| Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial A Tjärnlund, Q Tang, C Wick, M Dastmalchi, H Mann, JT Studýnková, ... Annals of the rheumatic diseases 77 (1), 55-62, 2018 | 129 | 2018 |
| TNF-α blockade induces IL-10 expression in human CD4+ T cells HG Evans, U Roostalu, GJ Walter, NJ Gullick, KS Frederiksen, ... Nature communications 5 (1), 3199, 2014 | 123 | 2014 |
| Linking power Doppler ultrasound to the presence of Th17 cells in the rheumatoid arthritis joint NJ Gullick, HG Evans, LD Church, DM Jayaraj, A Filer, BW Kirkham, ... PloS one 5 (9), e12516, 2010 | 106 | 2010 |
| Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127low regulatory T cells GJ Walter, HG Evans, B Menon, NJ Gullick, BW Kirkham, AP Cope, ... Arthritis & Rheumatism 65 (3), 627-638, 2013 | 104 | 2013 |
| Enhanced and persistent levels of interleukin (IL)-17+CD4+ T cells and serum IL-17 in patients with early inflammatory arthritis NJ Gullick, HS Abozaid, DM Jayaraj, HG Evans, DL Scott, EH Choy, ... Clinical & Experimental Immunology 174 (2), 292-301, 2013 | 73 | 2013 |
| Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise T Bharucha, A Rutherford, S Skeoch, A Alavi, M Brown, J Galloway, ... Clinical radiology 72 (9), 764-771, 2017 | 66 | 2017 |
| Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study … A Abhishek, RJ Boyton, N Peckham, Á McKnight, LC Coates, J Bluett, ... The Lancet Respiratory Medicine 10 (9), 840-850, 2022 | 63 | 2022 |
| Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review I Al-Shakarchi, NJ Gullick, DL Scott Patient preference and adherence, 653-666, 2013 | 37 | 2013 |
| Patient involvement in rheumatology outpatient service design and delivery: a case study S de Souza, J Galloway, C Simpson, R Chura, J Dobson, NJ Gullick, ... Health Expectations 20 (3), 508-518, 2017 | 34 | 2017 |
| Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound AN Mian, K Chaabo, J Wajed, S Subesinghe, NJ Gullick, B Kirkham, ... BMC Musculoskeletal Disorders 17, 1-5, 2016 | 34 | 2016 |
| An examination of work instability, functional impairment, and disease activity in employed patients with rheumatoid arthritis A Macedo, S Oakley, N Gullick, B Kirkham The Journal of rheumatology 36 (2), 225-230, 2009 | 34 | 2009 |
| Psoriatic disease and body composition: a systematic review and narrative synthesis T Blake, NJ Gullick, CE Hutchinson, TM Barber PloS one 15 (8), e0237598, 2020 | 32 | 2020 |
| Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis N Gullick, I Ibrahim, Fowzia, Scott, A Vincent, A Cope, T Garrood, ... BMC Rheumatology 3, 6, 2019 | 30 | 2019 |
| FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+ CD25− responder T cells, but not CD4+ CD25+ regulatory T cells AL Jagger, HG Evans, GJ Walter, NJ Gullick, B Menon, LE Ballantine, ... Journal of autoimmunity 38 (1), 29-38, 2012 | 30 | 2012 |
| Secukinumab use in patients with moderate to severe psoriasis, psoriatic arthritis and ankylosing spondylitis in real-world setting in Europe: baseline data from SERENA study U Kiltz, PP Sfikakis, K Gaffney, PG Sator, R von Kiedrowski, A Bounas, ... Advances in therapy 37, 2865-2883, 2020 | 27 | 2020 |
| Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years NJ Gullick, SP Oakley, A Zain, T Gibson, T Jones, A Mistlin, JD Rees, ... Rheumatology 51 (4), 759-761, 2012 | 25 | 2012 |
